Breaking
Monday, June 22, 2026

Drug Approvals

🌏 NMPA Page 2

NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.

Showing 13–24 of 97 articles

High impact NewsJun 3, 2026

Regulatory Round-Up: Key Drug Approvals on May 18, 2026

FDA · 5 min

Dr. Yuki Tanaka
High impact NewsJun 3, 2026

Optical Coherence Tomography Gains Regulatory Traction in Pharma Filings

FDA · 6 min

Dr. Yuki Tanaka
High impact NewsJun 3, 2026

Datroway Approved: A New Hope for Metastatic TNBC Patients

FDA · metastatic TNBC · 5 min

Dr. Yuki Tanaka
High impact AnalysisJun 3, 2026

Kelun-Biotech Secures New Drug Approval for SKB118: Investor and BD Guide

FDA · oncology · 5 min

Dr. Yuki Tanaka
High impact AnalysisJun 3, 2026

AbbVie Secures FDA Approval for ImmunoGen's Elahere

FDA · rare blood cancers · 6 min

Dr. Yuki Tanaka
High impact NewsJun 3, 2026

PREMIA and Lind Launch Lind Asia to Revolutionize Clinical Trials with AI

FDA · 5 min

Dr. Yuki Tanaka
High impact NewsJun 3, 2026

PMDA Approves New Pharmaceuticals and Medical Devices: What's New

PMDA · 4 min

Dr. Yuki Tanaka
High impact AnalysisJun 2, 2026

Shionogi's Xocova Gains FDA Clearance for COVID-19 Post-Exposure Prevention

FDA · COVID-19 · 7 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

Global Regulatory Agencies Update Real-World Evidence Guidance for Decision-Making

7 min

Dr. Yuki Tanaka
High impact NewsJun 2, 2026

China's Ascendancy in Oncology Research Alarms European Oncologists, Threatening Europe's Competitive Edge

oncology · 9 min

Dr. Yuki Tanaka
High impact NewsJun 2, 2026

ASCO 2026: Asian Oncology Innovation Takes Center Stage, Driving Global Clinical Trial Advancements

oncology · 6 min

Dr. Yuki Tanaka
High impact AnalysisJun 2, 2026

CDER Leadership Changes: Navigating the Impact on Pharmaceutical Strategy

FDA · 11 min

Dr. Yuki Tanaka